Search
for
Sort by
Research 241–270 of 1000+
- 66-Year-Old Woman With Painless Vesicular Lesions
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Androgen treatment in women
- Safety of testosterone use in women
- Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century
- Nutritional Management of Menopausal Women
- Telogen effluvium
- Androgenic effects of oral contraceptives: Implications for patient compliance
- Safety of testosterone treatment in postmenopausal women
- Androgen Receptor Actions Modify Skin Structure and Chemical Carcinogen-induced Skin Cancer Susceptibility in Mice
- Measurement of steroid hormones by liquid chromatography-tandem mass spectrometry with small amounts of hair
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- Hormonal therapy for acne: why not as first line therapy? facts and controversies
- Kisspeptin and LH pulsatile temporal coupling in PCOS patients
- Oxidative Activity of the Type 2 Isozyme of 17β-Hydroxysteroid Dehydrogenase (17β-HSD) Predominates in Human Sebaceous Glands
- Cutaneous Side Effects of Oral Contraceptives
- Comprehensive analysis of circRNAs from cashmere goat skin by next generation RNA sequencing (RNA-seq)
- Prescribing testosterone and DHEA: The role of androgens in women
- Stem cells and aberrant signaling of molecular systems in skin aging
- Hormone therapy in acne
- Testosterone implants in women: Pharmacological dosing for a physiologic effect
- What is the Rationale for Androgen Therapy for Women?
- Finasteride delays the onset of maternal behavior in primigravid rats
- Nutrition of women with hair loss problem during the period of menopause
- Desideratum dermatologicum--cause and control of premenstrual acne flare
- Androgen excess and post-reproductive health
- Progestogens in menopausal hormone therapy
- The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men
- Monocyclic Aromatic Compounds
- Pediatric Endocrine-Disrupting Chemical Exposure Produces Irreversible Organizational Injury: Biomarker Evidence Necessitating a Precautionary Public Health Framework